| EU/1/13/861/002 |
7046A |
PROCYSBI 75 mg tvrdé gastrorezistentné kapsuly |
cps end 250x75 mg (f?.HDPE) |
CHS |
|
| EU/1/13/861/001 |
7045A |
PROCYSBI 25 mg tvrdé gastrorezistentné kapsuly |
cps end 60x25 mg (f?.HDPE) |
CHS |
|
| EU/1/09/528/002 |
07849 |
Peyona 20 mg/ml infúzny intravenózny roztok a perorálny roztok |
sol ipr 10x1 ml/20 mg (amp.skl.) |
CHS |
|
| EU/1/09/528/001 |
78430 |
Peyona 20 mg/ml infúzny intravenózny roztok a perorálny roztok |
sol ipr 10x3 ml/60 mg (amp.skl.) |
CHS |
|
| 14/0106/04-S |
64765 |
Budiair 0,2 mg |
sol inh 1x11,2 ml/200 dávok (obal Al tlakový) |
CHS |
|
| 29/0114/99-S |
49522 |
Flamexin 20 mg |
tbl 30x191,2 mg (blis.PVC/PVDC/Al/PVDC) |
CHS |
|
| 29/0114/99-S |
49520 |
Flamexin 20 mg |
tbl 10x191,2 mg (blis.PVC/PVDC/Al/PVDC) |
CHS |
|
| 29/0114/99-S |
34494 |
Flamexin 20 mg |
tbl 60x191,2 mg (blis.PVC/PVDC/Al/PVDC) |
CHS |
|
| 87/0210/99-S |
87227 |
Curosurf 240 mg |
int etu 1x3 ml/240 mg (liek.inj.skl.) |
CHS |
|
| 87/0209/99-S |
87226 |
Curosurf 120 mg |
int etu 2x1,5 ml/120 mg (liek.inj.skl.) |
CHS |
|
| 29/0114/99-S |
49503 |
Flamexin 20 mg |
tbl 20x191,2 mg (blis.PVC/PVDC/Al/PVDC) |
CHS |
|
| 14/0506/12-S |
3781B |
Foster Nexthaler |
plv inh 3x120 dávok (inhalátor PA/Al/PE viacdávkový) |
CHS-AT |
|
| 14/0506/12-S |
3780B |
Foster Nexthaler |
plv inh 2x120 dávok (inhalátor PA/Al/PE viacdávkový) |
CHS-AT |
|
| 14/0506/12-S |
3779B |
Foster Nexthaler |
plv inh 1x120 dávok (inhalátor PA/Al/PE viacdávkový) |
CHS-AT |
|
| 14/0506/12-S |
3313A |
Foster Nexthaler |
plv inh 3x120 dávok (inhalátor PET/Al/PE viacdávkový) |
CHS-AT |
|
| 14/0506/12-S |
3312A |
Foster Nexthaler |
plv inh 2x120 dávok (inhalátor PET/Al/PE viacdávkový) |
CHS-AT |
|
| 14/0506/12-S |
3311A |
Foster Nexthaler |
plv inh 1x120 dávok (inhalátor PET/Al/PE viacdávkový) |
CHS-AT |
|
| 65/0214/04-S |
86840 |
Sufentanil Chiesi 5 µg/ ml |
sol inj 5x2 ml (amp.skl.) |
CHS-AT |
|
| 15/0534/06-S |
66877 |
Bramitob |
sol neb 4x4 ml/300 mg (amp.PE jednodávk.) |
CHS-AT |
|
| 14/0110/07-S |
65146 |
Foster |
sol inh 2x120 dávok (obal Al tlakový) |
CHS-AT |
|
| 68/0395/08-S |
52755 |
Xomolix |
sol inj 10x1 ml/2,5 mg (amp.skl.) |
CHS-AT |
|
| 14/0110/07-S |
38996 |
Foster |
sol inh 1x180 dávok (obal Al tlakový) |
CHS-AT |
|
| 14/0110/07-S |
38995 |
Foster |
sol inh 1x120 dávok (obal Al tlakový) |
CHS-AT |
|
| 15/0534/06-S |
37450 |
Bramitob |
sol neb 56x4 ml/300 mg (amp.PE jednodávk.) |
CHS-AT |
|
| 15/0534/06-S |
37449 |
Bramitob |
sol neb 28x4 ml/300 mg (amp.PE jednodávk.) |
CHS-AT |
|
| 15/0534/06-S |
37448 |
Bramitob |
sol neb 16x4 ml/300 mg (amp.PE jednodávk.) |
CHS-AT |
|
| 14/0164/05-S |
95559 |
Atimos 12 µg inhala?ný roztok v tlakovom obale |
sol inh 1x50 dávok/600 µg +aplikátor |
CHS-AT |
|
| 14/0164/05-S |
91632 |
Atimos 12 µg inhala?ný roztok v tlakovom obale |
sol inh 1x120 dávok/1440 µg +aplikátor |
CHS-AT |
|
| 14/0164/05-S |
91631 |
Atimos 12 µg inhala?ný roztok v tlakovom obale |
sol inh 1x100 dávok/1200 µg +aplikátor |
CHS-AT |
|
| 44/0147/05-S |
91538 |
Pamitor 15 mg/ml |
con inf 4x6 ml/90 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91537 |
Pamitor 15 mg/ml |
con inf 4x4 ml/60 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91536 |
Pamitor 15 mg/ml |
con inf 4x2 ml/30 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91534 |
Pamitor 15 mg/ml |
con inf 4x1 ml/15 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91533 |
Pamitor 15 mg/ml |
con inf 1x6 ml/90 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91530 |
Pamitor 15 mg/ml |
con inf 1x4 ml/60 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91528 |
Pamitor 15 mg/ml |
con inf 1x2 ml/30 mg (amp.PE) |
CHS-AT |
|
| 44/0147/05-S |
91527 |
Pamitor 15 mg/ml |
con inf 1x1 ml/15 mg (amp.PE) |
CHS-AT |
|
| 65/0215/04-S |
21092 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 20x20 ml (amp.skl.) |
CHS-AT |
|
| 65/0215/04-S |
21091 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 10x20 ml (amp.skl.) |
CHS-AT |
|
| 65/0215/04-S |
30783 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 5x20 ml (amp.skl.) |
CHS-AT |
|
| 65/0215/04-S |
21090 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 20x5 ml (amp.skl.) |
CHS-AT |
|
| 65/0215/04-S |
21089 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 10x5 ml (amp.skl.) |
CHS-AT |
|
| 65/0215/04-S |
21088 |
Sufentanil Chiesi 50 µg/ ml |
sol inj 5x5 ml (amp.skl.) |
CHS-AT |
|
| 65/0214/04-S |
21044 |
Sufentanil Chiesi 5 µg/ ml |
sol inj 20x10 ml (amp.skl.) |
CHS-AT |
|
| 65/0214/04-S |
21043 |
Sufentanil Chiesi 5 µg/ ml |
sol inj 10x10 ml (amp.skl.) |
CHS-AT |
|
| 65/0214/04-S |
30779 |
Sufentanil Chiesi 5 µg/ ml |
sol inj 5x10 ml (amp.skl.) |
CHS-AT |
|
| 69/0158/99-S |
84575 |
Otobacid N |
int ots 1x5 ml (liek.skl.) |
CHS-AT |
|
| EU/1/14/987/001 |
3265B |
Holoclar 79 000 - 316 000 buniek/cm2 transplantát |
tra 1x3,8 cm2 (nádoba- nehrdz.oce?) |
CHS |
19.02.2019 |
| EU/1/14/935/009 |
1096B |
Envarsus 4 mg tablety s pred?ženým uvo??ovaním |
tbl plg 90x4 mg (blis.PVC/Al) |
CHS |
18.07.2019 |
| EU/1/14/935/008 |
1095B |
Envarsus 4 mg tablety s pred?ženým uvo??ovaním |
tbl plg 60x4 mg (blis.PVC/Al) |
CHS |
18.07.2019 |
1
2
